Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03344848 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of the Orion Visual Cortical Prosthesis System
A NA study of Blindness, Acquired, sponsored by Second Sight Medical Products.
- Active
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 2
- Study locations
NCT03344848: Active NA study of Blindness, Acquired, sponsored by Second Sight Medical Products.
NCT03344848 is a NA study of Blindness, Acquired that is active but no longer recruiting, run by Second Sight Medical Products. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03344848, a NA study of Blindness, Acquired, is active but no longer recruiting, sponsored by Second Sight Medical Products.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an early feasibility study of a new device, the Orion Visual Cortical Prosthesis System. The device is intended to stimulate the surface of the visual cortex to induce visual perception in blind individuals.
Primary Outcome
Collection of adverse events
Conditions Studied
Interventions
- DEVICE Orion Visual Cortical Prosthesis System
Study Locations (2)
California
- University of California, Los Angeles - Los Angeles
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-11-20 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What the registry record for NCT03344848 still lists
NCT03344848 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Blindness, Acquired appearing as the primary indexed condition, and to 1 intervention - of which Orion Visual Cortical Prosthesis System is the first listed.
NCT03344848 reports a single indexed study location in California, Texas.
Frequently Asked Questions
What is clinical trial NCT03344848 about?
NCT03344848 is a clinical study titled "Early Feasibility Study of the Orion Visual Cortical Prosthesis System". This is an early feasibility study of a new device, the Orion Visual Cortical Prosthesis System. The device is intended to stimulate the surface of the visual cortex to induce visual perception in blind individuals.
What is the current status of trial NCT03344848?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2017-11-20. Estimated completion is 2025-03-31.
What conditions does trial NCT03344848 study?
This clinical trial studies the following conditions: Blindness, Acquired.
What interventions are being tested in trial NCT03344848?
The interventions under investigation include: Orion Visual Cortical Prosthesis System (DEVICE).
Who is sponsoring clinical trial NCT03344848?
This trial is sponsored by Second Sight Medical Products, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03344848 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blindness, Acquired
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03344848's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI